|
MAPK9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.242480E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.216020E-03 |
| Normal-vs-Stage2 |
3.352000E-01 |
| Normal-vs-Stage3 |
6.554800E-04 |
| Normal-vs-Stage4 |
9.033600E-04 |
| Stage1-vs-Stage2 |
1.661030E-01 |
| Stage1-vs-Stage3 |
3.219200E-01 |
| Stage1-vs-Stage4 |
4.628000E-01 |
| Stage2-vs-Stage3 |
5.330000E-02 |
| Stage2-vs-Stage4 |
8.458300E-02 |
| Stage3-vs-Stage4 |
9.651000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.846200E-04 |
| Normal-vs-AfricanAmerican |
1.382800E-01 |
| Normal-vs-Asian |
6.552000E-04 |
| Caucasian-vs-AfricanAmerican |
4.806400E-01 |
| Caucasian-vs-Asian |
5.103600E-01 |
| AfricanAmerican-vs-Asian |
3.554800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.640090E-02 |
| Normal-vs-Female |
6.788900E-04 |
| Male-vs-Female |
3.884000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.044500E-04 |
| Normal-vs-Age(41-60Yrs) |
4.035400E-04 |
| Normal-vs-Age(61-80Yrs) |
8.512500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.545000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.563400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.005380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.901200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.719500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.894800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.573000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.478000E-01 |
| Classical-VS-Follicular |
1.586180E-01 |
| Classical-VS-Other |
1.735760E-01 |
| Classical-VS-Normal |
1.716810E-03 |
| Tall-VS-Follicular |
4.152100E-02 |
| Tall-VS-Other |
4.045600E-01 |
| Tall-VS-Normal |
1.524750E-03 |
| Follicular-VS-Other |
1.951780E-02 |
| Follicular-VS-Normal |
1.629170E-01 |
| Other-VS-Normal |
9.217600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.384600E-03 |
| Normal-vs-N1 |
3.69300000000461E-05 |
| N0-vs-N1 |
2.837500E-02 |
|
|
